(169 days)
The Microlife Digital Basal Thermometer is a device intended for measuring, and aiding in the monitoring and tracking of basal body temperature (BBT) as an aid in ovulation prediction to aid in conception (not to be used for contraception).
The Microlife Digital Basal Thermometer, which uses the Basal Temperature method can be used for helping in family planning in healthy adults by understanding their menstrual cycle and ovulation and interpreting basal temperature changes. This Thermometer provides easy, quick and highly accurate readings over the body temperature range. The body temperature is measured by the thermistor (inside the probe tip) and displayed as numbers on the LCD (liquid crystal diplay) through microprocessor of IC. The basic principle of this thermometer is that change of thermistor resistance, caused by changes of temperature, are converted to changes of frequency of R-C oscillator circuit. Therefore, temperature can be given by measuring the frequency of oscillator. For a given time period by applying to R-C oscillator circuit, changes of temperature will correspond to changes of pulse number.
The provided text describes the Microlife Digital Basal Thermometer and its 510(k) submission, confirming its substantial equivalence to a predicate device. However, it does not contain the detailed acceptance criteria or the specifics of a study that proves the device meets those criteria in the way requested by the prompt.
The document states:
- "Controlled human clinical studies were conducted using the Microlife Digital Basal Thermometer MT1921 for measurement and accuracy."
- "Compliance to applicable voluntary standards includes ASTM E1112, as well as IEC60601-1 and IEC60601-1-2 requirements."
- "Guidance documents included the "FDA Guidance on the Content of Premarket Notification 510(K) Submissions for Clinical Electronic Thermometers."
While these statements indicate that testing was performed and standards were met, the actual acceptance criteria values and the results of those tests are not provided in the summary. Therefore, directly filling out most of the requested fields is not possible from the given input.
Based on the provided text, here's what can be extracted and what cannot:
1. Table of acceptance criteria and the reported device performance:
| Acceptance Criteria (Not explicitly stated in document) | Reported Device Performance (Generalized statements) |
|---|---|
| Specific temperature accuracy limits (e.g., ±0.1°C) | Met ASTM E1112, IEC60601-1, IEC60601-1-2 |
| Specific measurement time limits | Easy, quick, and highly accurate readings |
| Reproducibility/Precision metrics | Substantiated by controlled human clinical studies |
| Safety standards | Compliant with IEC60601-1 and IEC60601-1-2 |
| Effectiveness for BBT monitoring | Aiding in monitoring and tracking of BBT |
2. Sample size used for the test set and the data provenance:
- Sample size: Not specified.
- Data provenance: "Controlled human clinical studies were conducted," but country of origin and retrospective/prospective nature are not specified.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not specified. The document does not describe the establishment of a ground truth by experts for the clinical studies.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- Not specified.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not applicable/Not done. This device is a thermometer, not an AI-assisted diagnostic tool that would involve "human readers" or "AI improvement." The study focused on the accuracy of the device itself.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- This device is a standalone electronic thermometer. The "controlled human clinical studies" would have assessed the device's performance in human subjects, implying a standalone assessment of the device's ability to measure temperature.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- Given it's a thermometer, the ground truth for accuracy would typically be a reference thermometer or a calibrated temperature standard against which the device's readings are compared. This is implied by "measurement and accuracy" testing and compliance with ASTM E1112 (Standard Specification for Electronic Thermometers for Intermittent Determination of Patient Temperature).
8. The sample size for the training set:
- Not applicable/Not specified. This device is a hardware-based electronic thermometer, not an AI/ML algorithm that requires a separate training set. The "human clinical studies" are for validation/testing, not training.
9. How the ground truth for the training set was established:
- Not applicable. (See #8)
{0}------------------------------------------------
K030961
Attachment #2b
510(K) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92.
The assigned 510(k) number is:
1. Submitter's Identification:
Microlife Intellectual Property GmbH, Switzerland Max Schmidheiny-Strasse 201 9435 Heerbrugg / Switzerland
Date Summary Prepared: March 24, 2003
2. Name of the Device:
Microlife Digital Basal Thermometer
3. Predicate Device Information:
B-D Digital Basal Thermometer, Model 524560 K#94527
4. Device Description:
The Microlife Digital Basal Thermometer, which uses the Basal Temperature method can be used for helping in family planning in healthy adults by understanding their menstrual cycle and ovulation and interpreting basal temperature changes. This Thermometer provides easy, quick and highly accurate readings over the body temperature range. The body temperature is measured by the thermistor (inside the probe tip) and displayed as numbers on the LCD (liquid crystal diplay) through microprocessor of IC.
The basic principle of this thermometer is that change of thermistor resistance, caused by changes of temperature, are converted to changes of frequency of R-C oscillator circuit. Therefore, temperature can be given by measuring the frequency of oscillator.
For a given time period by applying to R-C oscillator circuit, changes of temperature will correspond to changes of pulse number.
{1}------------------------------------------------
5. Intended Use:
The Microlife Digital Basal Thermometer is a device intended for measuring, and aiding in the monitoring and tracking of basal body temperature (BBT) as an aid in ovulation prediction to aid in conception (not to be used for contraception).
6. Comparison to Predicate Devices:
The Microlife Digital Basal Thermometer, Model MT1921 is substantially equivalent to B-D Digital Basal Thermometer, Model 524560 K#94527 which have the same intended use and are similar in design to the predicate device.
The Microlife Digital Basal Thermometer MT1921 and the predicate device are identical in functionality and performance with the difference being the external shape of the devices, PCB layout of the devices, ergonomics of the user interface, dimensional specifications, probe tip connection to probe wire for temperature measuring and housing material used.
7. Discussion of Non-Clinical Tests Performed for Determination of Substantial Equivalence are as follows:
Compliance to applicable voluntary standards includes ASTM E1112, as well as IEC60601-1 and IEC60601-1-2 requirements.
Guidance documents included the "FDA Guidance on the Content of Premarket Notification 510(K) Submissions for Clinical Electronic Thermometers.
8. Discussion of Clinical Tests Performed:
Controlled human clinical studies were conducted using the Microlife Digital Basal Thermometer MT1921 for measurement and accuracy.
9. Conclusions:
The Microlife Digital Basal Thermometer has the same intended use and similar technological characteristics as the B-D Digital Basal thermometer Model 524560,.Moreover, bench testing contained in this submission supplied demonstrates that any differences in their characteristics do not raise any new questions of safety or effectiveness. Thus, the Microlife Digital Basal Thermometer is substantially equivalent to the predicate device.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows a logo with a stylized bird in flight, composed of three curved lines that suggest movement and feathers. The bird is encircled by text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES" in a circular arrangement. The logo is rendered in black and white, giving it a simple and clean appearance.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP 1 2 2003
Microlife Intellectual Property Ms. Susan D. Goldstein-Falk Official Correspondent mdi Consultants. Inc. 55 Northern Blvd. GREAT NECK NY 11021
Re: K030961
Trade/Device Name: Microlife Digital Basal Thermometer Model MT 1921 Regulation Number: None Regulatory Class: I Product Code: 85 LHD Dated: July 24, 2003 Received: July 25, 2003
Dear Ms. Goldstein-Falk:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
{3}------------------------------------------------
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of the letter:
| 8xx.1xxx | (301) 594-4591 |
|---|---|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
. Attachment #2a
Page -1 of 1
510(k) Number (if known): _ Ko3 09 b l
Device Name Microlife Digital Basal Thermometer MT 1921
Indications For Use:
The Microlife Digital Basal Thermometer is a device intended for measuring, and aiding in the monitoring and tracking of basal body temperature (BBT) as an aid in ovulation prediction to aid in conception (not to be used for contraception).
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Over-The-Counter Use
(Division Sign-Off) Division of Reproductive and Radiological De 510(k) Number
N/A